Process economics evaluation and optimization of adeno‐associated virus downstream processing
Biotechnology and Bioengineering · 2024-08 · 121 (8) · 2435-2448
DOI: 10.1002/bit.28402 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2023-04-22. Written by Annabel Lyle and 6 co-authors. Institution: Department of Biochemical Engineering, The Advanced Centre for Biochemical Engineering, University College London, London, UK. Major MEDLINE topics: Dependovirus. Cited 37 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY 4.0). Funded by: AstraZeneca, Engineering and Physical Sciences Research Council, University College London.
Abstract (original language)
Adeno‐associated virus (AAV) manufacturing has traditionally focused upon lab‐scale techniques to culture and purify vector products, leading to limitations in production capacity. The tool presented in this paper assesses the feasibility of using non‐scalable technologies at high AAV demands and identifies optimal flowsheets at large‐scale that meet both cost and purity targets. The decisional tool comprises (a) a detailed process economics model with the relevant mass balance, sizing, and costing equations for AAV upstream and downstream technologies, (b) a built‐in Monte Carlo simulation to assess uncertainties, and (c) a brute‐force optimization algorithm for rapid investigation into the optimal purification combinations. The results overall highlighted that switching to more scalable upstream and downstream processing alternatives is economically advantageous. The base case analysis showed the cost and robustness advantages of utilizing suspension cell culture over adherent, as well as a fully chromatographic purification platform over batch ultracentrifugation. Expanding the set of purification options available gave insights into the optimal combination to satisfy both cost and purity targets. As the purity target increased, the optimal polishing solution moved from the non‐capsid purifying multimodal chromatography to anion‐exchange chromatography or continuous ultracentrifugation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biochemical Engineering, The Advanced Centre for Biochemical Engineering, University College London, London, UK.
- Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
- Biopharmaceuticals Development, R&D, AstraZeneca, Cambridge, UK.
Funding
- AstraZeneca
- Engineering and Physical Sciences Research Council
- University College London
Cite
APA
Lyle, A., Stamatis, C., Linke, T., Hulley, M., Schmelzer, A., Turner, R., & Farid, S. S. (2024). Process economics evaluation and optimization of adeno‐associated virus downstream processing. Biotechnology and Bioengineering, 121(8), 2435-2448. https://doi.org/10.1002/bit.28402
Vancouver
Lyle A, Stamatis C, Linke T, Hulley M, Schmelzer A, Turner R, et al. Process economics evaluation and optimization of adeno‐associated virus downstream processing. Biotechnology and Bioengineering. 2024;121(8):2435-2448. doi:10.1002/bit.28402
BibTeX
@article{Lyle2024,
author = {Lyle, Annabel and Stamatis, Christos and Linke, Thomas and Hulley, Martyn and Schmelzer, Albert and Turner, Richard and Farid, Suzanne S},
title = {Process economics evaluation and optimization of adeno‐associated virus downstream processing},
journal = {Biotechnology and Bioengineering},
year = {2024},
volume = {121},
number = {8},
pages = {2435--2448},
doi = {10.1002/bit.28402}
}
EUVIMED